Cancer: Repositioned to kill stem cells

Nature

Volumn 525, Issue 7569, 2015, Pages 328-329

  Holyoake, Tessa ^a   Vetrie, David ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC TRIOXIDE; AXITINIB; BROMODOMAIN INHIBITOR; HYDROXYCHLOROQUINE; IMATINIB; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PIOGLITAZONE; PROTEIN TYROSINE KINASE INHIBITOR; STAT5 PROTEIN; 2,4 THIAZOLIDINEDIONE DERIVATIVE; ANTINEOPLASTIC AGENT; BENZAMIDE DERIVATIVE; PIPERAZINE DERIVATIVE; PYRIMIDINE DERIVATIVE;

CANCER; CELLS AND CELL COMPONENTS; CHEMOTHERAPY; DISEASE CONTROL; DRUG;

BCR ABL1 GENE; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CANCER STEM CELL; CANCER SURVIVAL; CHRONIC MYELOID LEUKEMIA; DISEASE FREE SURVIVAL; DRUG REPOSITIONING; HUMAN; NONHUMAN; PHASE 2 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; SHORT SURVEY; TUMOR GENE; UNSPECIFIED SIDE EFFECT; AGONISTS; DRUG EFFECTS; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; PATHOLOGY;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BENZAMIDES; HUMANS; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; NEOPLASTIC STEM CELLS; PIPERAZINES; PPAR GAMMA; PYRIMIDINES; THIAZOLIDINEDIONES;

EID: 84942035567     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature15213     Document Type: Short Survey

References (7)

1. Prost, S. et al. Nature 525, 380-383 (2015).
2. Daley, G. Q., Van Etten, R. A. & Baltimore, D. Science 247, 824-830 (1990).
3. Kranc, K. R. et al. Cell Stem Cell 5, 659-665 (2009).
4. Ito, K. et al. Nature 453, 1072-1078 (2008).
5. Bellodi, C. et al. J. Clin. Invest. 119, 1109-1123 (2009).
6. Pemovska, T. et al. Nature 519, 102-105 (2015).
7. Prost, S. et al. J. Clin. Invest. 118, 1765-1775 (2008).